Current Progress in CAR-T Cell Therapy for Hematological Malignancies

Immunotherapies, such as monoclonal antibody therapy and checkpoint inhibitor therapy, have shown inspiring clinical effects for the treatment of cancer. Chimeric antigen receptor T (CAR-T) cells therapy was an efficacious therapeutic approach treating hematological malignancies and encouraging resu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cancer
Main Authors: Han, Donglei, Xu, Zenghui, Zhuang, Yuan, Ye, Zhenlong, Qian, Qijun
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738987/
https://ncbi.nlm.nih.gov/pubmed/33391429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.48976
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki